NCT01784939View on ClinicalTrials.gov

HEPFER-Evaluation of a New Phenotypic Biological Marker in Genetic Type 1 Hemochromatosis

CompletedOBSERVATIONAL
Enrollment

31

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Hereditary Hemochromatosis C282Y Homozygous
Trial Locations (1)

35000

CHU, Rennes

All Listed Sponsors
lead

Rennes University Hospital

OTHER

NCT01784939 - HEPFER-Evaluation of a New Phenotypic Biological Marker in Genetic Type 1 Hemochromatosis | Biotech Hunter | Biotech Hunter